A subset of 38 NSCLC patients (Rs n = 28, NRs n = 10) for which both BiomeOne® predictions and PD-L1 expression data were available were compared regarding specificity and sensitivity [23]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.